A newly published New England Journal of Medicine trial adds stronger evidence behind Ajovy for some children and teens with episodic migraine. The study found modest average benefit, not a cure, and the current U.S. label applies only to patients ages 6 to 17 who weigh 45 kg or more.
Roche’s FDA-cleared pTau181 blood test brings Alzheimer’s biomarker testing closer to everyday care, but right now it is mainly for adults 55 and older who already have cognitive symptoms, and a positive result still usually needs more workup. ([accessdata.fda.gov](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K252163))
FDA-approved anti-amyloid drugs such as lecanemab are now in real-world use for early Alzheimer’s disease. Here’s who qualifies, what the main clinical trial showed, what ARIA risks mean, and how Medicare coverage works in the United States.
FDA traditional approval of lecanemab for early Alzheimer’s disease offers modest slowing of decline for some patients—but requires careful screening, MRI monitoring, and meeting Medicare coverage rules. Here’s what families should understand in 2026.
Using headache medicines too often can sometimes make headaches worse instead of better. Here’s what U.S. experts say about medication overuse headache—how it happens, who’s at risk, and how to break the cycle safely.
Anti-amyloid antibody treatments such as lecanemab are now part of Alzheimer’s care in the United States—but only for certain patients. Here’s who qualifies, what Medicare covers, how MRI safety monitoring works, and what families should realistically expect.
FDA-approved anti-amyloid drugs like lecanemab can modestly slow early Alzheimer’s disease—but they are not cures. Here’s who qualifies, what the clinical trials showed, the real risks, and how Medicare coverage works in 2026.
Stroke remains a leading cause of death and long-term disability in the United States. Here’s what the most recent CDC data shows, who is at highest risk, and what everyday prevention steps can lower your chances.
A rare condition called congenital insensitivity to pain may sound like a superpower. In reality, it can be life-threatening. Here’s what researchers know, what remains a mystery, and what it means for everyday health.
Hearing loss affects millions of Americans across all ages. Here’s what current public health guidance says about causes, prevention, over-the-counter hearing aids, and when to seek care.
Headaches are common, but not all are the same. Here’s what U.S. health experts say about types of headaches, warning signs, treatment options, and when to seek medical care.
New and ongoing guidance from U.S. public health agencies highlights practical steps people can take to lower their risk of stroke, dementia, and other brain-related conditions. Here’s what matters most for everyday life.
Dementia is not an inevitable part of aging. Here’s what major public health agencies and medical journals say about protecting brain health—and what it means for you and your family.
Hearing loss affects millions of Americans across all ages. Here’s what the latest federal guidance and research say about risk factors, over-the-counter hearing aids, prevention, and when to seek care.
Most headaches are not dangerous, but some need medical attention. Here’s how to tell the difference, what current guidance says about treatment, and when to see a doctor.
Stroke remains a leading cause of death and long-term disability in the United States. Here’s what the latest public health guidance says about symptoms, treatment timing, risk factors, and practical prevention steps.
Knowing when to see a neurologist can prevent complications and speed recovery. This article explains the key warning signs of nerve or brain problems—sudden weakness or numbness, severe or new headaches, changes in vision, speech, or balance, seizures or tremors, memory or thinking issues, and persistent tingling, pain, or back/neck symptoms that radiate into a limb—and flags emergencies like possible stroke (face droop, arm weakness, speech trouble: call emergency services). It also outlines what to expect at an appointment, including a neurological exam and tests such as MRI/CT, EEG, or EMG, and the range of conditions neurologists treat, from migraines and neuropathy to epilepsy and multiple sclerosis. Patients and caregivers will find practical tips for tracking symptoms, preparing questions, and seeking timely referrals, with reassurance that early evaluation leads to safer, tailored care and better outcomes.
Neurology is the medical specialty focused on the brain, spinal cord, nerves, and muscles—helping diagnose and treat issues like headaches and migraines, stroke, epilepsy, multiple sclerosis, Parkinson’s disease, neuropathy, and memory changes. This beginner’s guide explains when to seek a neurologist, what to expect at an appointment (history, neurological exam, and tests like MRI, EEG, or EMG), and the range of treatments available, from medications and rehabilitation to lifestyle changes and procedures. It also highlights how neurologists work with a care team—including primary care, therapists, and, when needed, neurosurgeons—to support long-term health. Clear, reliable information empowers patients and caregivers to recognize symptoms, ask informed questions, and partner in decisions that improve quality of life.
This article demystifies common neurology tests—like MRIs, EEGs, CT scans, nerve conduction studies/EMG, and lumbar punctures—so you know what each test looks for, what to expect during the procedure, and how results inform diagnosis and treatment. It explains how these tests help evaluate symptoms such as seizures, headaches, memory changes, neuropathy, and suspected stroke or multiple sclerosis. You’ll find clear guidance on preparation, comfort and safety, timing, and potential risks, plus practical questions to ask your care team. Designed for patients and caregivers, it aims to reduce anxiety, build confidence, and help you make informed decisions together with your clinician.
This article clearly explains how neurology and neurosurgery differ and helps you decide who to see for brain, spine, and nerve concerns. Neurologists diagnose and medically manage conditions like migraines, seizures, neuropathy, and multiple sclerosis using tools such as MRI, EEG, and EMG, along with medications, injections, and therapy. Neurosurgeons treat problems that may require operations—such as brain tumors, aneurysms, hydrocephalus, and severe spine issues—and often collaborate closely with neurologists. You’ll find practical guidance on where to start (often with your primary care doctor or a neurologist for evaluation and referral), what to expect at appointments, and urgent red flags that warrant emergency care (sudden weakness or numbness, facial droop, slurred speech, “worst headache,” or head injury). The goal is to help patients and caregivers feel supported and confident in getting the right expertise at the right time.
In 2025, neurology is shifting toward earlier, more personalized, and less invasive care that meaningfully improves daily life. Blood-based biomarkers and AI-enhanced imaging are speeding diagnosis and helping match patients to the right treatments, while disease‑modifying options are expanding—from anti‑amyloid therapies for Alzheimer’s and genetics‑guided approaches in ALS to next‑generation therapies for MS and new migraine preventives. Targeted neuromodulation and wearable monitoring are reducing symptoms and hospital visits in epilepsy and movement disorders, and stroke care is faster and more effective with streamlined thrombolysis, improved thrombectomy, and home‑based rehabilitation. For patients, caregivers, and information seekers, these advances translate into clearer choices, more care delivered at home, better function with fewer side effects, and greater access to clinical trials when standard options are limited.
Ultra-processed foods (UPFs) such as chips, sodas, and processed meats are increasingly under scrutiny due to their high concentrations of microplastics, which have been linked to mental health concerns. Recent studies in Brain Medicine reveal that these microplastics can cross the blood-brain barrier…
End of content
End of content
